Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: By terms of nodal stations, zones, chains, and a composite

被引:13
|
作者
Zheng, Hui [1 ]
Wang, Lin-mao [1 ]
Bao, Fang [1 ]
Jiang, Ge-ning [1 ]
Xie, Hui-kang [2 ]
Ding, Jia-an [1 ]
Hu, Xue-fei [1 ]
Chen, Chang [1 ]
机构
[1] Tongji Univ, Surg Shanghai Pulm Hosp, Dept Gen Thorac, Sch Med, Shanghai 200433, Peoples R China
[2] Tongji Univ, Shanghai Pulm Hosp, Dept Pathol, Sch Med, Shanghai 200433, Peoples R China
关键词
Non-small-cell lung cancer; TNM classification; N2; stage; Lymphadenectomy; Lymphatic metastasis; Prognosis; PROGNOSTIC-FACTORS; INTERNATIONAL ASSOCIATION; NODES; METASTASIS; SURVIVAL; NUMBER; CLASSIFICATION; CHEMOTHERAPY; INVOLVEMENT;
D O I
10.1016/j.lungcan.2011.03.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: N2 non-small-cell lung cancer (NSCLC) is a heterogeneous disease with an extremely wide range of 5-year survival rates. A composite method of sub-classification for N2 is likely to provide a more accurate method to more finely differentiate prognosis of N2 disease. Methods: A total of 720 pN2 (T1-4N2M0) NSCLC cases were enrolled in our retrospective analysis of the proposed composite method. Survival rates were respectively calculated according to the N2 stratification methods: singly by "nodal stations", "nodal zones", or "nodal chains", or by combination of all three. Statistical analysis was carried out by Kaplan-Meier and Cox regression models. Results: A total of 10,199 lymph nodes (8059 mediastinal; 2140 hilar and intra-lobar) were removed. By nodal station, there were 173 cases of single-station involvement and 547 multi-stations. By nodal zone, there were 413 single-zone involvement and 307 with multiple zones. By nodal chain, there were 311 cases with single-chain and 409 multi-chain involvements. The overall 5-year survival was 20% and median survival time was 27.52 months. The 5-year survival was significantly better for cases of single-zone involvement, as compared to multi-zones (29% vs. 6%, p < 0.0001). The 5-year survival rates of single- and multi-chains involvement were 36% and 8%, respectively (p < 0.0001). When taking all of the above grouping methods into consideration, the N2 disease state could be further sub-classified into two subgroups with respective survival rates of 36% and 7% (p < 0.0001). Subgroup I was composed of individuals with single-chain involvement and having either one or two station metastasis; individuals with any other metastasis combinations formed Subgroup II. Multivariate analysis revealed that the composite sub-classification method, number of positive lymph nodes, ratio of nodal metastasis, and pT information were the most important risk factors of 5-year survival. Conclusions: By combining the three N2 stratification methods based on "stations", "zones", and "chains" into one composite method, prognosis prediction was more accurate for N2 NSCLC disease. Single nodal chain involvement, which may be either one or two nodal stations metastasis, is associated with best outcome for pN2 patients. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:497 / 503
页数:7
相关论文
共 50 条
  • [1] N2 disease in non-small-cell lung cancer: straight to surgery?
    Sanchez-Lorente, David
    Guzman, Rudith
    Boada, Marc
    Guirao, Angela
    Carriel, Nicole
    Molins, Laureano
    FUTURE ONCOLOGY, 2018, 14 (06) : 13 - 16
  • [2] Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer
    Garelli, Elena
    Renaud, Stephane
    Falcoz, Pierre-Emmanuel
    Weingertner, Noelle
    Olland, Anne
    Santelmo, Nicola
    Massard, Gilbert
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 50 (02) : 322 - 328
  • [3] Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma
    Benoit, L.
    Anusca, A.
    Ortega-Deballon, P.
    Cheynel, N.
    Bernard, A.
    Favre, J. P.
    EJSO, 2006, 32 (05): : 583 - 587
  • [4] Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer
    Kamigaichi, Atsushi
    Tsutani, Yasuhiro
    Mimae, Takahiro
    Miyata, Yoshihiro
    Shimada, Yoshihisa
    Ito, Hiroyuki
    Nakayama, Haruhiko
    Ikeda, Norihiko
    Okada, Morihito
    CLINICAL LUNG CANCER, 2021, 22 (02) : 120 - +
  • [5] Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease
    Kim, Hong Kwan
    Cho, Jong Ho
    Choi, Yong Soo
    Zo, Jae Ill
    Shim, Young Mog
    Park, Keunchil
    Ahn, Myung-Ju
    Ahn, Yong Chan
    Kim, Kwhanmien
    Kim, Jhingook
    LUNG CANCER, 2016, 96 : 56 - 62
  • [6] Clinicopathologic correlates of postoperative N1 or N2 nodal upstaging in non-small cell lung cancer
    Moon, Youngkyu
    Lee, Kyo Young
    Kim, Kyung Soo
    Park, Jae Kil
    JOURNAL OF THORACIC DISEASE, 2016, 8 (01) : 79 - 85
  • [7] Postoperative radiotherapy in resected N2 non-small-cell lung cancer: Lung ART Comment
    Hendriks, Lizza E. L.
    De Ruysscher, Dirk K. M.
    LANCET ONCOLOGY, 2022, 23 (01) : 8 - 9
  • [8] New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery
    Tsitsias, Thomas
    Okiror, Lawrence
    Veres, Lukacs
    King, Juliet
    Harrison-Phipps, Karen
    Routledge, Tom
    Pilling, John
    Bille, Andrea
    LUNG CANCER, 2021, 151 : 84 - 90
  • [9] A MULTICENTER RETROSPECTIVE ANALYSIS OF SURVIVAL OUTCOME FOLLOWING POSTOPERATIVE CHEMORADIOTHERAPY IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH N2 NODAL DISEASE
    Zou, Bingwen
    Xu, Yong
    Li, Tao
    Li, Wenhui
    Tang, Bangxian
    Zhou, Lin
    Li, Lu
    Liu, Yongmei
    Zhu, Jiang
    Huang, Meijuan
    Wang, Jin
    Ren, Li
    Gong, Youlin
    Che, Guowei
    Liu, Lunxu
    Hou, Mei
    Lu, You
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (02): : 321 - 328
  • [10] Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspectiveaEuro
    Rocco, Gaetano
    Nason, Katie
    Brunelli, Alex
    Varela, Gonzalo
    Waddell, Thomas
    Jones, David R.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (04) : 1025 - 1027